NasdaqCM:YGYI

Stock Analysis Report

Executive Summary

Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally.


Snowflake Analysis

High growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has Youngevity International's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: YGYI's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-39.9%

YGYI

-8.8%

US Personal Products

-2.0%

US Market


1 Year Return

-89.2%

YGYI

-21.8%

US Personal Products

-15.1%

US Market

Return vs Industry: YGYI underperformed the US Personal Products industry which returned -19.9% over the past year.

Return vs Market: YGYI underperformed the US Market which returned -14.9% over the past year.


Shareholder returns

YGYIIndustryMarket
7 Day-39.9%-8.8%-2.0%
30 Day-53.8%-25.5%-19.7%
90 Day-82.2%-30.9%-23.2%
1 Year-89.2%-89.2%-20.7%-21.8%-13.4%-15.1%
3 Year-88.4%-88.4%16.7%11.0%10.9%3.7%
5 Year-87.9%-87.9%10.5%-1.3%28.4%14.4%

Price Volatility Vs. Market

How volatile is Youngevity International's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Youngevity International undervalued compared to its fair value and its price relative to the market?

0.33x

Price to Book (PB) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate YGYI's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate YGYI's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: YGYI is unprofitable, so we can't compare its PE Ratio to the Personal Products industry average.

PE vs Market: YGYI is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate YGYI's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: YGYI is good value based on its PB Ratio (0.3x) compared to the US Personal Products industry average (1.8x).


Next Steps

Future Growth

How is Youngevity International forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

111.2%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: YGYI is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1.7%).

Earnings vs Market: YGYI is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: YGYI's is expected to become profitable in the next 3 years.

Revenue vs Market: YGYI's revenue (21.3% per year) is forecast to grow faster than the US market (7.1% per year).

High Growth Revenue: YGYI's revenue (21.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if YGYI's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Youngevity International performed over the past 5 years?

-73.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: YGYI is currently unprofitable.

Growing Profit Margin: YGYI is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: YGYI is unprofitable, and losses have increased over the past 5 years at a rate of -73.3% per year.

Accelerating Growth: Unable to compare YGYI's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: YGYI is unprofitable, making it difficult to compare its past year earnings growth to the Personal Products industry (25.5%).


Return on Equity

High ROE: YGYI has a negative Return on Equity (-51.48%), as it is currently unprofitable.


Next Steps

Financial Health

How is Youngevity International's financial position?


Financial Position Analysis

Short Term Liabilities: YGYI's short term assets ($72.3M) exceed its short term liabilities ($58.8M).

Long Term Liabilities: YGYI's short term assets ($72.3M) exceed its long term liabilities ($26.2M).


Debt to Equity History and Analysis

Debt Level: YGYI's debt to equity ratio (27.5%) is considered satisfactory.

Reducing Debt: YGYI's debt to equity ratio has reduced from 37.6% to 27.5% over the past 5 years.


Balance Sheet

Inventory Level: YGYI has a high level of physical assets or inventory.

Debt Coverage by Assets: YGYI's debt is covered by short term assets (assets are 4.7x debt).


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: YGYI has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: YGYI has less than a year of cash runway if free cash flow continues to reduce at historical rates of -53.2% each year


Next Steps

Dividend

What is Youngevity International's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate YGYI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate YGYI's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if YGYI's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if YGYI's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of YGYI's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

8.8yrs

Average management tenure


CEO

Steve Wallach (52yo)

8.75s

Tenure

US$434,439

Compensation

Mr. Stephan Wallach, also known as Steve, has been the Chief Executive Officer of Youngevity International Inc. (formerly, AL International Inc.) since July 11, 2011 and served as its President. Mr. Wallac ...


CEO Compensation Analysis

Compensation vs Market: Steve's total compensation ($USD434.44K) is about average for companies of similar size in the US market ($USD609.32K).

Compensation vs Earnings: Steve's compensation has increased whilst the company is unprofitable.


Leadership Team

NamePositionTenureCompensationOwnership
Stephan Wallach
Chairman & CEO 8.75yrsUS$434.44k23.13% $4.3m
David Briskie
President9.25yrsUS$1.00m1.72% $322.2k
Michelle Wallach
Chief Operating Officer8.75yrsUS$214.58k23.12% $4.3m
Joel Wallach
Co-Founderno datano datano data
Ma Lan
Co-Founder & Member of the Scientific Advisory Boardno datano datano data
Brad Kenson
Chief Technology Officer4.42yrsno datano data
Jonnie Taylor
Senior Executive Vice President of Customer Serviceno datano datano data
Raffy Lorentzian
VP & Controller6.83yrsno datano data
Dwayne Dundore
President of Khrysosno datano datano data
Wiley Hurt
VP of Global Operations & Senior Project Managerno datano datano data

8.8yrs

Average Tenure

58yo

Average Age

Experienced Management: YGYI's management team is seasoned and experienced (8.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Stephan Wallach
Chairman & CEO 8.75yrsUS$434.44k23.13% $4.3m
David Briskie
President9.25yrsUS$1.00m1.72% $322.2k
Joel Wallach
Co-Founderno datano datano data
Ma Lan
Co-Founder & Member of the Scientific Advisory Boardno datano datano data
William Thompson
Independent Director6.83yrsUS$74.24kno data
Gerhard Schrauzer
Member of the Scientific Advisory Boardno datano datano data
James Sensenig
Member of the Scientific Advisory Boardno datano datano data
Richard Renton
Member of Science & Athletic Advisory Boardsno dataUS$74.24k0.076% $14.3k
Mike Glenn
Chairman of the Athletic Advisory Boardno datano datano data
Paul Sallwasser
Independent Director2.83yrsUS$74.24k0.25% $47.6k

7.5yrs

Average Tenure

58yo

Average Age

Experienced Board: YGYI's board of directors are considered experienced (7.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 33.2%.


Top Shareholders

Company Information

Youngevity International, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Youngevity International, Inc.
  • Ticker: YGYI
  • Exchange: NasdaqCM
  • Founded: 1996
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$18.737m
  • Shares outstanding: 30.27m
  • Website: https://www.ygyi.com

Number of Employees


Location

  • Youngevity International, Inc.
  • 2400 Boswell Road
  • Chula Vista
  • California
  • 91914
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
YGYINasdaqCM (Nasdaq Capital Market)YesCommon StockUSUSDJul 2011
2OVBST (Boerse-Stuttgart)YesCommon StockDEEURJul 2011
YGYI.PNasdaqCM (Nasdaq Capital Market)9.75% PFD SER DUSUSDSep 2019

Biography

Youngevity International, Inc. develops and distributes health and nutrition related products and services in the United States and internationally. It operates in three segments: Direct Selling, Commercial Coffee, and Commercial Hemp. The company offers nutritional supplements, gourmet coffee, weight management products, skincare and cosmetics, health and wellness, packaged foods, lifestyle products, pet care, digital products, telecare health services, apparel and fashion accessories, and business lending products. It also produces and sells coffee products under the Café La Rica, Café Alma, Josie’s Java House, Javalution Urban Grind, Javalution Daily Grind, and Javalution Royal Roast brands; and produces and markets a line of coffees under the JavaFit brand directly to consumers. In addition, it offers cannabidiol oils from hemp stock. The company sells coffee and equipment to wellness and retirement communities, and various cruise lines and coffee service operators, as well as through distribution network. Youngevity International, Inc. also markets its products through a range of consumer Websites, such as youngevity.com; ygyi.com; heritagemakers.com; hempfx.com; clrroasters.com; cafelarica.com; javalution.com. The company was formerly known as AL International, Inc. and changed its name to Youngevity International, Inc. in July 2013. Youngevity International, Inc. was founded in 1996 and is headquartered in Chula Vista, California. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/04 01:55
End of Day Share Price2020/04/03 00:00
Earnings2019/09/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.